AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
2024

Gene Therapy for Hereditary Deafness: Progress and Perspectives

Sample size: 11 publication 10 minutes Evidence: high

Author Information

Author(s): Liyan Zhang, Fangzhi Tan, Jieyu Qi, Yicheng Lu, Xiaohan Wang, Xuehan Yang, Xiangyan Chen, Xinru Zhang, Jinyi Fan, Yinyi Zhou, Li Peng, Nianci Li, Lei Xu, Shiming Yang, Renjie Chai

Primary Institution: Southeast University, China

Hypothesis

Can gene therapy effectively treat hereditary deafness caused by genetic mutations?

Conclusion

Gene therapy has shown promising results in restoring hearing function in patients with hereditary deafness, particularly those with OTOF mutations.

Supporting Evidence

  • Gene therapy has restored hearing in over 20 types of genetic deafness model mice.
  • Clinical trials have shown significant improvements in auditory function in patients with OTOF mutations.
  • Gene therapy approaches are required for different genetic forms of deafness due to the complexity of the inner ear.

Takeaway

Scientists are using special medicine to help kids who can't hear because of their genes, and it's working really well for some of them.

Methodology

This review summarizes preclinical and clinical research on gene therapy for hereditary deafness, focusing on advancements and challenges.

Limitations

The complexity of the inner ear and the diversity of deafness genes complicate the precision of gene therapy.

Participant Demographics

The study involved children aged 5 to 8 years with hereditary deafness due to OTOF mutations.

Digital Object Identifier (DOI)

10.1002/advs.202402166

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication